Comparative bioavailability study under fasting conditions research hub

Randomized, open-label, laboratory-blinded, balanced, single dose, 3-treatment, 6-sequence, 3-period crossover comparative bioavailability study comparing Finerenone, 20 mg, film-coated tablets (Prototype 1, Prototype 2) and Kerendia, 20 mg, film-coated tablets under fasting conditions in healthy participants.

This study is comparing two new versions of a medicine called Finerenone with an existing one, Kerendia. We want to see how much of the medicine your body absorbs from each version when you haven't eaten. It's for healthy adults.